Localized Prostate Cancer Program

About Alessa Therapeutics

Alessa Therapeutics is an early-stage biotech targeting the significant unmet need in localized prostate cancer treatment. The company is advancing a proprietary drug-delivery platform intended to enable localized, sustained release of established therapeutic agents directly to the prostate, potentially offering a more effective and tolerable alternative to active surveillance or radical therapies. Led by a seasoned team with strong academic roots from UCSF and venture backing from Cure Ventures, Alessa is positioned to develop a paradigm-shifting approach in urologic oncology, though it remains in the pre-clinical or early clinical development stage.

Therapeutic Areas